| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone modifying activity | 4.26e-06 | 229 | 22 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 6.34e-05 | 11 | 22 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 6.34e-05 | 11 | 22 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 7.60e-05 | 12 | 22 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 2.18e-04 | 20 | 22 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 2.89e-04 | 23 | 22 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | FAD binding | 1.07e-03 | 44 | 22 | 2 | GO:0071949 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.07e-03 | 44 | 22 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.32e-03 | 775 | 22 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.43e-03 | 51 | 22 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.66e-03 | 55 | 22 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.97e-03 | 60 | 22 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.53e-03 | 68 | 22 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.60e-03 | 69 | 22 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.75e-03 | 71 | 22 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.31e-03 | 78 | 22 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 4.76e-03 | 94 | 22 | 2 | GO:0050660 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 5.58e-03 | 102 | 22 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 5.69e-03 | 103 | 22 | 2 | GO:0008276 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 5.80e-03 | 104 | 22 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 5.91e-03 | 105 | 22 | 2 | GO:0008170 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 1.46e-02 | 473 | 22 | 3 | GO:0004842 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.52e-02 | 172 | 22 | 2 | GO:0008757 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.80e-02 | 512 | 22 | 3 | GO:0019787 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.80e-02 | 188 | 22 | 2 | GO:0005201 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.99e-02 | 532 | 22 | 3 | GO:0016755 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.07e-04 | 14 | 23 | 2 | GO:2001046 | |
| GeneOntologyCellularComponent | laminin-5 complex | 6.94e-06 | 4 | 23 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 2.42e-05 | 7 | 23 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 3.23e-05 | 8 | 23 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | laminin complex | 5.18e-05 | 10 | 23 | 2 | GO:0043256 | |
| HumanPheno | Duplicated collecting system | 1.97e-05 | 24 | 12 | 3 | HP:0000081 | |
| HumanPheno | Abnormal renal collecting system morphology | 3.91e-05 | 30 | 12 | 3 | HP:0004742 | |
| HumanPheno | Renal necrosis | 5.07e-05 | 5 | 12 | 2 | HP:0032618 | |
| HumanPheno | Pyoderma | 5.07e-05 | 5 | 12 | 2 | HP:0000999 | |
| HumanPheno | Renal tubular epithelial necrosis | 5.07e-05 | 5 | 12 | 2 | HP:0008682 | |
| HumanPheno | Ureteral obstruction | 8.71e-05 | 39 | 12 | 3 | HP:0006000 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 1.06e-04 | 7 | 12 | 2 | HP:0020117 | |
| HumanPheno | Alopecia of scalp | 1.34e-04 | 45 | 12 | 3 | HP:0002293 | |
| HumanPheno | Mitten deformity | 1.81e-04 | 9 | 12 | 2 | HP:0004057 | |
| HumanPheno | Congenital localized absence of skin | 1.81e-04 | 9 | 12 | 2 | HP:0007383 | |
| HumanPheno | Abnormal dermatological laboratory findings | 2.27e-04 | 10 | 12 | 2 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 2.27e-04 | 10 | 12 | 2 | HP:0003341 | |
| HumanPheno | Subepidermal blistering | 2.77e-04 | 11 | 12 | 2 | HP:0033804 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 2.77e-04 | 11 | 12 | 2 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 3.31e-04 | 12 | 12 | 2 | HP:0031538 | |
| HumanPheno | Nail dystrophy | 3.46e-04 | 156 | 12 | 4 | HP:0008404 | |
| HumanPheno | Blistering by histological location | 3.91e-04 | 13 | 12 | 2 | HP:0033801 | |
| HumanPheno | Decreased circulating IgG subclass concentration | 3.91e-04 | 13 | 12 | 2 | HP:0032135 | |
| HumanPheno | Ureteral duplication | 4.40e-04 | 67 | 12 | 3 | HP:0000073 | |
| HumanPheno | Oral mucosal blisters | 4.56e-04 | 14 | 12 | 2 | HP:0200097 | |
| HumanPheno | Renal duplication | 4.80e-04 | 69 | 12 | 3 | HP:0000075 | |
| HumanPheno | Abdominal organ duplication | 4.80e-04 | 69 | 12 | 3 | HP:0005217 | |
| HumanPheno | Squamous cell carcinoma | 5.22e-04 | 71 | 12 | 3 | HP:0002860 | |
| HumanPheno | Carious teeth | 5.25e-04 | 174 | 12 | 4 | HP:0000670 | |
| HumanPheno | Hoarse cry | 5.25e-04 | 15 | 12 | 2 | HP:0001615 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 5.99e-04 | 16 | 12 | 2 | HP:0010476 | |
| HumanPheno | Scarring alopecia of scalp | 5.99e-04 | 16 | 12 | 2 | HP:0004552 | |
| HumanPheno | Laryngeal stenosis | 5.99e-04 | 16 | 12 | 2 | HP:0001602 | |
| HumanPheno | Paronychia | 5.99e-04 | 16 | 12 | 2 | HP:0001818 | |
| HumanPheno | Urethral stricture | 6.78e-04 | 17 | 12 | 2 | HP:0012227 | |
| HumanPheno | Milia | 6.78e-04 | 17 | 12 | 2 | HP:0001056 | |
| HumanPheno | Dysuria | 7.62e-04 | 18 | 12 | 2 | HP:0100518 | |
| HumanPheno | Abnormal fingertip morphology | 9.42e-04 | 203 | 12 | 4 | HP:0001211 | |
| HumanPheno | Esophageal stricture | 9.44e-04 | 20 | 12 | 2 | HP:0002043 | |
| HumanPheno | Unexplained fevers | 9.44e-04 | 20 | 12 | 2 | HP:0001955 | |
| HumanPheno | Abnormality of the periungual region | 1.14e-03 | 22 | 12 | 2 | HP:0100803 | |
| HumanPheno | Multicystic kidney dysplasia | 1.34e-03 | 98 | 12 | 3 | HP:0000003 | |
| HumanPheno | Enamel hypoplasia | 1.59e-03 | 104 | 12 | 3 | HP:0006297 | |
| HumanPheno | Blistering by anatomical location | 1.60e-03 | 26 | 12 | 2 | HP:0033800 | |
| Domain | PWWP | 1.60e-06 | 20 | 22 | 3 | SM00293 | |
| Domain | Znf_PHD-finger | 2.05e-06 | 79 | 22 | 4 | IPR019787 | |
| Domain | EPHD | 2.15e-06 | 22 | 22 | 3 | PS51805 | |
| Domain | PWWP | 2.47e-06 | 23 | 22 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.47e-06 | 23 | 22 | 3 | IPR000313 | |
| Domain | PWWP | 2.83e-06 | 24 | 22 | 3 | PS50812 | |
| Domain | PHD | 3.30e-06 | 89 | 22 | 4 | SM00249 | |
| Domain | Znf_PHD | 3.61e-06 | 91 | 22 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.28e-06 | 95 | 22 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 4.47e-06 | 96 | 22 | 4 | PS01359 | |
| Domain | - | 1.00e-05 | 449 | 22 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.14e-05 | 459 | 22 | 6 | IPR013083 | |
| Domain | Znf_FYVE_PHD | 2.41e-05 | 147 | 22 | 4 | IPR011011 | |
| Domain | Enhancer_polycomb-like_N | 3.69e-05 | 8 | 22 | 2 | IPR019542 | |
| Domain | EPL1 | 3.69e-05 | 8 | 22 | 2 | PF10513 | |
| Domain | Zinc_finger_PHD-type_CS | 5.91e-05 | 65 | 22 | 3 | IPR019786 | |
| Domain | PHD | 9.07e-05 | 75 | 22 | 3 | PF00628 | |
| Domain | LAMININ_NTER | 1.57e-04 | 16 | 22 | 2 | PS51117 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 22 | 2 | PF00055 | |
| Domain | Post-SET_dom | 1.57e-04 | 16 | 22 | 2 | IPR003616 | |
| Domain | PostSET | 1.57e-04 | 16 | 22 | 2 | SM00508 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 22 | 2 | IPR008211 | |
| Domain | POST_SET | 1.57e-04 | 16 | 22 | 2 | PS50868 | |
| Domain | LamNT | 1.57e-04 | 16 | 22 | 2 | SM00136 | |
| Domain | Bromodomain_CS | 4.23e-04 | 26 | 22 | 2 | IPR018359 | |
| Domain | EGF_LAM_2 | 5.65e-04 | 30 | 22 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.65e-04 | 30 | 22 | 2 | PS01248 | |
| Domain | Laminin_EGF | 7.70e-04 | 35 | 22 | 2 | PF00053 | |
| Domain | EGF_Lam | 7.70e-04 | 35 | 22 | 2 | SM00180 | |
| Domain | BROMODOMAIN_1 | 8.60e-04 | 37 | 22 | 2 | PS00633 | |
| Domain | Laminin_EGF | 9.08e-04 | 38 | 22 | 2 | IPR002049 | |
| Domain | Bromodomain | 9.08e-04 | 38 | 22 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.06e-03 | 41 | 22 | 2 | PS50014 | |
| Domain | SET | 1.06e-03 | 41 | 22 | 2 | PF00856 | |
| Domain | BROMO | 1.11e-03 | 42 | 22 | 2 | SM00297 | |
| Domain | Bromodomain | 1.11e-03 | 42 | 22 | 2 | IPR001487 | |
| Domain | - | 1.11e-03 | 42 | 22 | 2 | 1.20.920.10 | |
| Domain | SET | 1.33e-03 | 46 | 22 | 2 | SM00317 | |
| Domain | SET_dom | 1.57e-03 | 50 | 22 | 2 | IPR001214 | |
| Domain | SET | 1.57e-03 | 50 | 22 | 2 | PS50280 | |
| Domain | EGF-like_dom | 2.99e-03 | 249 | 22 | 3 | IPR000742 | |
| Domain | EGF_1 | 3.20e-03 | 255 | 22 | 3 | PS00022 | |
| Domain | EGF-like_CS | 3.41e-03 | 261 | 22 | 3 | IPR013032 | |
| Domain | EGF_2 | 3.56e-03 | 265 | 22 | 3 | PS01186 | |
| Domain | RING | 5.28e-03 | 305 | 22 | 3 | SM00184 | |
| Domain | Galactose-bd-like | 5.42e-03 | 94 | 22 | 2 | IPR008979 | |
| Domain | Znf_RING | 6.34e-03 | 326 | 22 | 3 | IPR001841 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.56e-07 | 175 | 15 | 5 | MM14941 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.61e-06 | 272 | 15 | 5 | M29619 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.78e-05 | 11 | 15 | 2 | M158 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 5.78e-05 | 11 | 15 | 2 | M27372 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.34e-05 | 79 | 15 | 3 | M27643 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.10e-04 | 15 | 15 | 2 | M27161 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.36e-04 | 117 | 15 | 3 | M19248 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 4.22e-04 | 29 | 15 | 2 | MM15340 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.52e-04 | 30 | 15 | 2 | M27772 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 4.52e-04 | 30 | 15 | 2 | M27637 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.52e-04 | 30 | 15 | 2 | M27216 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 5.38e-04 | 155 | 15 | 3 | M522 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 5.47e-04 | 33 | 15 | 2 | M39503 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 5.59e-04 | 157 | 15 | 3 | MM15226 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 5.91e-04 | 160 | 15 | 3 | M27498 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.46e-04 | 41 | 15 | 2 | M27778 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 8.88e-04 | 42 | 15 | 2 | M27272 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.06e-03 | 46 | 15 | 2 | MM14933 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.06e-03 | 46 | 15 | 2 | MM14935 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.06e-03 | 46 | 15 | 2 | M239 | |
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 3.33e-07 | 21 | 23 | 3 | 22959728 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24333487 | ||
| Pubmed | Structural requirement for cell adhesion to kalinin (laminin-5). | 4.18e-07 | 2 | 23 | 2 | 7775432 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 9205497 | ||
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 1.25e-06 | 3 | 23 | 2 | 16179086 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 15373767 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 8113417 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 17137774 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 8012114 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 1.25e-06 | 3 | 23 | 2 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 1.25e-06 | 3 | 23 | 2 | 18603785 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 27375110 | ||
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 1.25e-06 | 3 | 23 | 2 | 16165127 | |
| Pubmed | Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. | 1.25e-06 | 3 | 23 | 2 | 20400950 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 33179081 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 1.25e-06 | 3 | 23 | 2 | 16537560 | |
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 1.25e-06 | 3 | 23 | 2 | 15149852 | |
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 1.25e-06 | 3 | 23 | 2 | 15854126 | |
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 1.25e-06 | 3 | 23 | 2 | 10853832 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 9019243 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 1.25e-06 | 3 | 23 | 2 | 17482449 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 10651091 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 22673183 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 21034821 | ||
| Pubmed | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. | 2.51e-06 | 4 | 23 | 2 | 19940114 | |
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 2.51e-06 | 4 | 23 | 2 | 10806203 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 26677226 | ||
| Pubmed | Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion. | 2.51e-06 | 4 | 23 | 2 | 24258712 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 8081888 | ||
| Pubmed | Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. | 2.51e-06 | 4 | 23 | 2 | 24065767 | |
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 14612440 | ||
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 4.18e-06 | 5 | 23 | 2 | 9271670 | |
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 16728390 | ||
| Pubmed | Laminin 5 regulates polycystic kidney cell proliferation and cyst formation. | 4.18e-06 | 5 | 23 | 2 | 16870608 | |
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 6.26e-06 | 6 | 23 | 2 | 9506922 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 20301304 | ||
| Pubmed | Structural and histone binding ability characterizations of human PWWP domains. | 6.26e-06 | 6 | 23 | 2 | 21720545 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 8.77e-06 | 7 | 23 | 2 | 9004048 | |
| Pubmed | Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. | 8.77e-06 | 7 | 23 | 2 | 20670891 | |
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 8.77e-06 | 7 | 23 | 2 | 18794358 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 1.17e-05 | 8 | 23 | 2 | 23529140 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.17e-05 | 8 | 23 | 2 | 9489770 | |
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 12482924 | ||
| Pubmed | 1.88e-05 | 10 | 23 | 2 | 9034910 | ||
| Pubmed | 2.29e-05 | 11 | 23 | 2 | 10811835 | ||
| Pubmed | Current insights into the formation and breakdown of hemidesmosomes. | 2.29e-05 | 11 | 23 | 2 | 16757171 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.29e-05 | 11 | 23 | 2 | 21524702 | |
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 2.29e-05 | 11 | 23 | 2 | 8707838 | |
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 9396756 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 9264260 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 4.37e-05 | 15 | 23 | 2 | 15895400 | |
| Pubmed | 4.53e-05 | 105 | 23 | 3 | 24667918 | ||
| Pubmed | Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. | 4.99e-05 | 16 | 23 | 2 | 12533516 | |
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 17601529 | ||
| Pubmed | 6.36e-05 | 18 | 23 | 2 | 11311202 | ||
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 22911573 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 7.89e-05 | 20 | 23 | 2 | 29785026 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 8.72e-05 | 21 | 23 | 2 | 27626377 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 27270040 | ||
| Pubmed | Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain. | 8.72e-05 | 21 | 23 | 2 | 25281266 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 27856617 | ||
| Pubmed | 1.35e-04 | 26 | 23 | 2 | 24742657 | ||
| Pubmed | 1.50e-04 | 157 | 23 | 3 | 30186101 | ||
| Pubmed | 1.68e-04 | 29 | 23 | 2 | 22613833 | ||
| Pubmed | 2.05e-04 | 32 | 23 | 2 | 23154389 | ||
| Pubmed | Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. | 2.90e-04 | 38 | 23 | 2 | 27653694 | |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 2.96e-04 | 198 | 23 | 3 | 20881960 | |
| Pubmed | 3.21e-04 | 40 | 23 | 2 | 27068110 | ||
| Pubmed | The chromatin regulator Brpf1 regulates embryo development and cell proliferation. | 3.21e-04 | 40 | 23 | 2 | 25773539 | |
| Pubmed | 3.54e-04 | 42 | 23 | 2 | 16387653 | ||
| Pubmed | 5.65e-04 | 591 | 23 | 4 | 15231748 | ||
| Pubmed | 6.08e-04 | 55 | 23 | 2 | 31985874 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.29e-04 | 608 | 23 | 4 | 36089195 | |
| Cytoband | 5q35.3 | 1.04e-03 | 95 | 23 | 2 | 5q35.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q35 | 6.15e-03 | 235 | 23 | 2 | chr5q35 | |
| GeneFamily | PWWP domain containing | 1.26e-06 | 22 | 18 | 3 | 1147 | |
| GeneFamily | PHD finger proteins | 1.67e-06 | 90 | 18 | 4 | 88 | |
| GeneFamily | Laminin subunits | 6.14e-05 | 12 | 18 | 2 | 626 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.15e-04 | 34 | 18 | 2 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.26e-02 | 718 | 18 | 3 | 28 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.13e-05 | 150 | 23 | 3 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.35e-05 | 173 | 23 | 3 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.02e-04 | 178 | 23 | 3 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.03e-04 | 179 | 23 | 3 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 179 | 23 | 3 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 179 | 23 | 3 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | control-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-04 | 180 | 23 | 3 | 592fb72cc344efff1bd3376d9f28c79745c61469 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 181 | 23 | 3 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 182 | 23 | 3 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 182 | 23 | 3 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 183 | 23 | 3 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.10e-04 | 183 | 23 | 3 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.12e-04 | 184 | 23 | 3 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 185 | 23 | 3 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 187 | 23 | 3 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 187 | 23 | 3 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.18e-04 | 187 | 23 | 3 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 187 | 23 | 3 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 188 | 23 | 3 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-04 | 188 | 23 | 3 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 189 | 23 | 3 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 189 | 23 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.21e-04 | 189 | 23 | 3 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 190 | 23 | 3 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 190 | 23 | 3 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 1.25e-04 | 191 | 23 | 3 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 191 | 23 | 3 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 191 | 23 | 3 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 192 | 23 | 3 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 192 | 23 | 3 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 193 | 23 | 3 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 193 | 23 | 3 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 193 | 23 | 3 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 195 | 23 | 3 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 195 | 23 | 3 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.35e-04 | 196 | 23 | 3 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 197 | 23 | 3 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 1.37e-04 | 197 | 23 | 3 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 197 | 23 | 3 | 8437c33e2c4a10a1b95343431e48d5e820b1f742 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 197 | 23 | 3 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 197 | 23 | 3 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | distal-1-Endothelial-Vein|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-04 | 198 | 23 | 3 | eee6cb4fe0e1caf460869d5a0a57c9d259573f10 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 198 | 23 | 3 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 198 | 23 | 3 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-04 | 198 | 23 | 3 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 198 | 23 | 3 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 198 | 23 | 3 | 71ee440b1ac566db63d0b415c50a0ad064d14f15 | |
| ToppCell | IIH-CD4-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.39e-04 | 198 | 23 | 3 | 85414b283bbcdbf3393ab1b4302ef0e21c7a8181 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 198 | 23 | 3 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.41e-04 | 199 | 23 | 3 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 23 | 3 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-04 | 199 | 23 | 3 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.41e-04 | 199 | 23 | 3 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 23 | 3 | 180b3997174fd63bdf3b828063a13483eb4cab29 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-04 | 199 | 23 | 3 | 523e01f6a0abd9820697572e042a381aae8932dc | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | (5)_Epi_suprabasal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.41e-04 | 199 | 23 | 3 | e1d0fd71b2f3925d02638413f2155db009f103d9 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 199 | 23 | 3 | 0d0d5cb821db16514192ad536849a8a04e22e637 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-04 | 199 | 23 | 3 | 68412bc39639edc4045437d62548f7101b9f1989 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 23 | 3 | bb2e839197b9a44b632c1bb716e48d885a1c8713 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-04 | 199 | 23 | 3 | dfd60380a29f99e187050933ee5252ec11c68a32 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 200 | 23 | 3 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.44e-04 | 200 | 23 | 3 | 413ac64bbe95b8c921c5396d8b5f298fec8c4f82 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 200 | 23 | 3 | cb00760ae75c30b1cb8526534aabd4ffc7c21000 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 200 | 23 | 3 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.44e-04 | 200 | 23 | 3 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 200 | 23 | 3 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | distal-Endothelial-Vein|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.44e-04 | 200 | 23 | 3 | 6acf7afe122f81a95c4c66f4d0878d997b57127a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.44e-04 | 200 | 23 | 3 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 23 | 3 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.44e-04 | 200 | 23 | 3 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-04 | 200 | 23 | 3 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-04 | 200 | 23 | 3 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.96e-04 | 91 | 23 | 2 | 3f56358ff0dacdf6b8fc22cea64082231bceb851 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-03 | 101 | 23 | 2 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.75e-03 | 121 | 23 | 2 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.81e-03 | 123 | 23 | 2 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | control-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.86e-03 | 125 | 23 | 2 | 30f593fadbe850cedd622711005f9069ad57cc03 | |
| ToppCell | ileum-Epithelial_Stem_Cells|ileum / shred on tissue and cell subclass | 1.89e-03 | 126 | 23 | 2 | a8ed48cbd1e207fd1aaad454fda9f329eb22aa83 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-03 | 126 | 23 | 2 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-03 | 127 | 23 | 2 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-03 | 130 | 23 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-03 | 131 | 23 | 2 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.11e-03 | 133 | 23 | 2 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-03 | 134 | 23 | 2 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.20e-03 | 136 | 23 | 2 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-03 | 140 | 23 | 2 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.36e-03 | 141 | 23 | 2 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.40e-03 | 142 | 23 | 2 | 671ba8869db7a6dc69fd1caf0e561f15a312b170 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-03 | 142 | 23 | 2 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.40e-03 | 142 | 23 | 2 | 3557084150670fd2e2634fc674f228ab85181b59 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.40e-03 | 142 | 23 | 2 | 6a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.40e-03 | 142 | 23 | 2 | a3d1f4b570b75402171e38c5a7c88e2896520c8f | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.43e-03 | 143 | 23 | 2 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-03 | 144 | 23 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| Computational | Neighborhood of CDH3 | 2.70e-04 | 27 | 10 | 2 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 2.91e-04 | 28 | 10 | 2 | GNF2_SERPINB5 | |
| Computational | Genes in the cancer module 153. | 4.30e-04 | 34 | 10 | 2 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.32e-04 | 50 | 10 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Genes in the cancer module 297. | 2.37e-03 | 80 | 10 | 2 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 2.37e-03 | 80 | 10 | 2 | MODULE_357 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.34e-06 | 28 | 23 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 1.74e-06 | 3 | 23 | 2 | cv:C0079683 | |
| Disease | Junctional epidermolysis bullosa | 1.74e-06 | 3 | 23 | 2 | cv:C0079301 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 1.74e-06 | 3 | 23 | 2 | 226700 | |
| Disease | Herlitz Disease | 3.48e-06 | 4 | 23 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 3.48e-06 | 4 | 23 | 2 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 5.80e-06 | 5 | 23 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 5.80e-06 | 5 | 23 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 5.80e-06 | 5 | 23 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 8.70e-06 | 6 | 23 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.22e-05 | 7 | 23 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.22e-05 | 7 | 23 | 2 | C0399367 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 2.84e-04 | 32 | 23 | 2 | EFO_0021870 | |
| Disease | complement factor D measurement | 2.38e-03 | 93 | 23 | 2 | EFO_0020283 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CHKANCYTAFHVTCA | 341 | O95696 | |
| YHEHCFVCAQCFRPF | 36 | Q7Z4I7 | |
| CNCHGHASNCYYDPD | 356 | Q16787 | |
| FYADSRHCVPCHKDC | 1361 | Q92824 | |
| FQVLNSCPCKCYCHH | 586 | Q86UU5 | |
| KCRHYFCESCALQHF | 276 | O15541 | |
| SCGEHFCNECFDHYY | 86 | Q8NB78 | |
| KFCDCCYCEFFGHNA | 411 | Q96PV7 | |
| THCLCHCKPYTFGAA | 471 | P10643 | |
| SCSSFFQQFFHCYCP | 401 | Q16526 | |
| CCKCDSRQPHNYYSH | 66 | Q13751 | |
| QHCASPAFAYCGHSF | 536 | Q9UKA1 | |
| HSCFTCACGQPAYAH | 151 | A4D161 | |
| FRDHKYCCDDPHSFF | 36 | Q6UWV7 | |
| HCGDFDYHRTCSYSC | 876 | Q9ULL8 | |
| ACIQCHKANCYTAFH | 396 | P55201 | |
| FKPFRCAHCHYSCNI | 991 | Q9P243 | |
| SFCEFCPHSFCKDHE | 1376 | Q9BZ95 | |
| PFHCNECGKVFSYHS | 371 | B4DU55 | |
| YAFHCPHCDFACSNK | 341 | P52746 | |
| KFHTYAVHCCCFSPS | 51 | Q8N9V3 | |
| FMASHFDRHYCGKCC | 131 | P62979 | |
| LFFCTSCGHHYHGAC | 241 | O14686 |